推动干细胞生物学向干细胞治疗发展。
Advancing stem cell biology toward stem cell therapeutics.
出版信息
Cell Stem Cell. 2012 Feb 3;10(2):149-50. doi: 10.1016/j.stem.2012.01.010.
Abstract
Here, the International Society for Stem Cell Research (ISSCR) Clinical Translation Committee introduces a series of disease-specific articles, outlining the challenges surrounding the clinical translation of stem cell therapeutics.
摘要
在此，国际干细胞研究学会（ISSCR）临床转化委员会介绍了一系列针对特定疾病的文章，概述了干细胞治疗临床转化所面临的挑战。
相似文献
1
Advancing stem cell biology toward stem cell therapeutics.
Cell Stem Cell. 2012 Feb 3;10(2):149-50. doi: 10.1016/j.stem.2012.01.010.
2
New ISSCR guidelines underscore major principles for responsible translational stem cell research.
Cell Stem Cell. 2008 Dec 4;3(6):607-9. doi: 10.1016/j.stem.2008.11.009.
3
Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.
Stem Cell Reports. 2016 Jun 14;6(6):787-797. doi: 10.1016/j.stemcr.2016.05.001. Epub 2016 May 12.
4
The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?
Stem Cell Reports. 2018 May 8;10(5):1429-1431. doi: 10.1016/j.stemcr.2018.04.010.
5
Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual Meeting.
Cell Stem Cell. 2012 Dec 7;11(6):765-7. doi: 10.1016/j.stem.2012.11.004.
6
The International Society for Stem Cell Research (ISSCR): history and perspectives.
Regen Med. 2006 May;1(3):373-6. doi: 10.2217/17460751.1.3.373.
7
Guidelines for stem cell science and clinical translation.
Indian J Med Ethics. 2016 Jul-Sep;1(3):160-1. doi: 10.20529/IJME.2016.044. Epub 2016 Jun 6.
8
Translating stem cell research: challenges at the research frontier.
J Law Med Ethics. 2010 Summer;38(2):267-76. doi: 10.1111/j.1748-720X.2010.00487.x.
9
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modeling.
Dis Model Mech. 2024 Jul 1;17(7). doi: 10.1242/dmm.050947. Epub 2024 Jul 8.
10
Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization.
Cell Stem Cell. 2010 Oct 8;7(4):451-4. doi: 10.1016/j.stem.2010.09.004.
引用本文的文献
1
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.
ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8.
2
Science, ethics and communication remain essential for the success of cell-based therapies.
Brain Circ. 2016 Jul-Sep;2(3):146-151. doi: 10.4103/2394-8108.192525. Epub 2016 Oct 18.
3
A single epidermal stem cell strategy for safe ex vivo gene therapy.
EMBO Mol Med. 2015 Apr;7(4):380-93. doi: 10.15252/emmm.201404353.
4
'Above all, do no harm': safeguarding pluripotent stem cell therapy against iatrogenic tumorigenesis.
Stem Cell Res Ther. 2014 Jun 3;5(3):73. doi: 10.1186/scrt462.
5
Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of , , , Controlled By Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their Death.
J Stem Cell Res Ther. 2013 Jul 22;Suppl 9(5). doi: 10.4172/2157-7633.S9-005.
6
Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.
J Cancer Res Ther (Manch). 2014;2(1):22-33. doi: 10.14312/2052-4994.2014-4.
7
A new class of pluripotent stem cell cytotoxic small molecules.
PLoS One. 2014 Mar 19;9(3):e85039. doi: 10.1371/journal.pone.0085039. eCollection 2014.
8
Cell-based therapeutics: the next pillar of medicine.
Sci Transl Med. 2013 Apr 3;5(179):179ps7. doi: 10.1126/scitranslmed.3005568.
9
A scalable approach to prevent teratoma formation of human embryonic stem cells.
J Biol Chem. 2012 Sep 21;287(39):32338-45. doi: 10.1074/jbc.M112.383810. Epub 2012 Aug 4.
Zotero 插件